APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Acute Ischemic Stroke Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Acute Ischemic Stroke Drugs Industry Growth and Trends Forecast to 2032

Report ID 173960300122 December 2025102 pages

Choose your research edition.

Industry ResearchAcute Ischemic Stroke Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Acute Ischemic Stroke Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Acute Ischemic Stroke Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acute Ischemic Stroke Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Acute Ischemic Stroke Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Acute Ischemic Stroke Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Acute Ischemic Stroke Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Acute Ischemic Stroke Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acute Ischemic Stroke Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Acute Ischemic Stroke Drugs market include Sanofi, Johnson＆Johnson, Roche, Pfizer, Biogen, Bayer, AstraZeneca, ZZ Biotech and SanBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Acute Ischemic Stroke Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Acute Ischemic Stroke Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acute Ischemic Stroke Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acute Ischemic Stroke Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Acute Ischemic Stroke Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Acute Ischemic Stroke Drugs Market by Company

Sanofi

Johnson＆Johnson

Roche

Pfizer

Biogen

Bayer

AstraZeneca

ZZ Biotech

SanBio

NoNO Inc

Daiichi Sankyo

Bristol-Myers Squibb

Boehringer Ingelheim

Athersys

Acute Ischemic Stroke Drugs Segment by Type

Tablet

Capsule

Other

Acute Ischemic Stroke Drugs Segment by Application

Hospitals

Diagnostic Centers

Others

Acute Ischemic Stroke Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Ischemic Stroke Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acute Ischemic Stroke Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Ischemic Stroke Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Acute Ischemic Stroke Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Acute Ischemic Stroke Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Acute Ischemic Stroke Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Acute Ischemic Stroke Drugs Market Share by Region (2021-2026) Table 4. Global Acute Ischemic Stroke Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Acute Ischemic Stroke Drugs Market Share by Region (2027-2032) Table 6. Global Acute Ischemic Stroke Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Acute Ischemic Stroke Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Acute Ischemic Stroke Drugs Market Size Share by Type (2021-2026) Table 9. Global Acute Ischemic Stroke Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Acute Ischemic Stroke Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Acute Ischemic Stroke Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Acute Ischemic Stroke Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Acute Ischemic Stroke Drugs Market Size Share by Application (2021-2026) Table 24. Global Acute Ischemic Stroke Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Acute Ischemic Stroke Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Acute Ischemic Stroke Drugs Industry Trends Table 37. Acute Ischemic Stroke Drugs Industry Drivers Table 38. Acute Ischemic Stroke Drugs Industry Opportunities and Challenges Table 39. Acute Ischemic Stroke Drugs Industry Restraints Table 40. Global Acute Ischemic Stroke Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Acute Ischemic Stroke Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Acute Ischemic Stroke Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Acute Ischemic Stroke Drugs Key Company Headquarters & Area Served Table 44. Global Acute Ischemic Stroke Drugs Company, Product Type & Application Table 45. Global Acute Ischemic Stroke Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Acute Ischemic Stroke Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi Acute Ischemic Stroke Drugs Product Portfolio Table 52. Sanofi Recent Development Table 53. Johnson＆Johnson Company Information Table 54. Johnson＆Johnson Business Overview Table 55. Johnson＆Johnson Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson＆Johnson Acute Ischemic Stroke Drugs Product Portfolio Table 57. Johnson＆Johnson Recent Development Table 58. Roche Company Information Table 59. Roche Business Overview Table 60. Roche Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Roche Acute Ischemic Stroke Drugs Product Portfolio Table 62. Roche Recent Development Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Acute Ischemic Stroke Drugs Product Portfolio Table 67. Pfizer Recent Development Table 68. Biogen Company Information Table 69. Biogen Business Overview Table 70. Biogen Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Biogen Acute Ischemic Stroke Drugs Product Portfolio Table 72. Biogen Recent Development Table 73. Bayer Company Information Table 74. Bayer Business Overview Table 75. Bayer Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bayer Acute Ischemic Stroke Drugs Product Portfolio Table 77. Bayer Recent Development Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AstraZeneca Acute Ischemic Stroke Drugs Product Portfolio Table 82. AstraZeneca Recent Development Table 83. ZZ Biotech Company Information Table 84. ZZ Biotech Business Overview Table 85. ZZ Biotech Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. ZZ Biotech Acute Ischemic Stroke Drugs Product Portfolio Table 87. ZZ Biotech Recent Development Table 88. SanBio Company Information Table 89. SanBio Business Overview Table 90. SanBio Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. SanBio Acute Ischemic Stroke Drugs Product Portfolio Table 92. SanBio Recent Development Table 93. NoNO Inc Company Information Table 94. NoNO Inc Business Overview Table 95. NoNO Inc Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. NoNO Inc Acute Ischemic Stroke Drugs Product Portfolio Table 97. NoNO Inc Recent Development Table 98. Daiichi Sankyo Company Information Table 99. Daiichi Sankyo Business Overview Table 100. Daiichi Sankyo Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Daiichi Sankyo Acute Ischemic Stroke Drugs Product Portfolio Table 102. Daiichi Sankyo Recent Development Table 103. Bristol-Myers Squibb Company Information Table 104. Bristol-Myers Squibb Business Overview Table 105. Bristol-Myers Squibb Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bristol-Myers Squibb Acute Ischemic Stroke Drugs Product Portfolio Table 107. Bristol-Myers Squibb Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Acute Ischemic Stroke Drugs Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Athersys Company Information Table 114. Athersys Business Overview Table 115. Athersys Acute Ischemic Stroke Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Athersys Acute Ischemic Stroke Drugs Product Portfolio Table 117. Athersys Recent Development Table 118. North America Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Acute Ischemic Stroke Drugs Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Acute Ischemic Stroke Drugs Market Share by Country (2021-2026) Table 121. North America Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Acute Ischemic Stroke Drugs Market Share Forecast by Country (2027-2032) Table 123. Europe Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Acute Ischemic Stroke Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Acute Ischemic Stroke Drugs Market Share by Country (2021-2026) Table 126. Europe Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Acute Ischemic Stroke Drugs Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Country (2021-2026) Table 131. Asia-Pacific Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Acute Ischemic Stroke Drugs Market Share Forecast by Country (2027-2032) Table 133. Latin America Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Acute Ischemic Stroke Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Acute Ischemic Stroke Drugs Market Share by Country (2021-2026) Table 136. Latin America Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Acute Ischemic Stroke Drugs Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Country (2021-2026) Table 141. Middle East & Africa Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Acute Ischemic Stroke Drugs Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Acute Ischemic Stroke Drugs Product Image Figure 3. Global Acute Ischemic Stroke Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Acute Ischemic Stroke Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Acute Ischemic Stroke Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Acute Ischemic Stroke Drugs Market Share by Region (2021-2032) Figure 7. North America Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Tablet Image Figure 13. Global Tablet Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Capsule Image Figure 15. Global Capsule Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Acute Ischemic Stroke Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Acute Ischemic Stroke Drugs Market Share by Type 2025 VS 2032 Figure 20. North America Acute Ischemic Stroke Drugs Market Size Share by Type (2021-2032) Figure 21. Europe Acute Ischemic Stroke Drugs Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Acute Ischemic Stroke Drugs Market Size Share by Type (2021-2032) Figure 23. Latin America Acute Ischemic Stroke Drugs Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Acute Ischemic Stroke Drugs Market Size Share by Type (2021-2032) Figure 25. Hospitals Image Figure 26. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Diagnostic Centers Image Figure 28. Global Diagnostic Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Acute Ischemic Stroke Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Acute Ischemic Stroke Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Acute Ischemic Stroke Drugs Market Size Share by Application (2021-2032) Figure 34. Europe Acute Ischemic Stroke Drugs Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Acute Ischemic Stroke Drugs Market Size Share by Application (2021-2032) Figure 36. Latin America Acute Ischemic Stroke Drugs Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Acute Ischemic Stroke Drugs Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Acute Ischemic Stroke Drugs Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Acute Ischemic Stroke Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Acute Ischemic Stroke Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Acute Ischemic Stroke Drugs Market Share by Country (2021-2032) Figure 43. Europe Acute Ischemic Stroke Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Acute Ischemic Stroke Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Acute Ischemic Stroke Drugs Market Share by Country (2021-2032) Figure 46. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Country (2021-2032) Figure 49. Latin America Acute Ischemic Stroke Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Acute Ischemic Stroke Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Acute Ischemic Stroke Drugs Market Share by Country (2021-2032) Figure 52. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Hospitals
  • Diagnostic Centers
  • Others
Companies covered
  • Sanofi
  • Johnson＆Johnson
  • Roche
  • Pfizer
  • Biogen
  • Bayer
  • AstraZeneca
  • ZZ Biotech
  • SanBio
  • NoNO Inc
  • Daiichi Sankyo
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Athersys

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Acute Ischemic Stroke Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Acute Ischemic Stroke Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Acute Ischemic Stroke Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Acute Ischemic Stroke Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Acute Ischemic Stroke Drugs Market Size (2021-2032)
  8. 1.5.1 North America Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Acute Ischemic Stroke Drugs Market Size Growth Rate (2021-2032)
2 Acute Ischemic Stroke Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Tablet
  3. 2.1.2 Capsule
  4. 2.1.3 Other
  5. 2.2 Global Acute Ischemic Stroke Drugs Market Size by Type
  6. 2.2.1 Global Acute Ischemic Stroke Drugs Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Acute Ischemic Stroke Drugs Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Acute Ischemic Stroke Drugs Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Acute Ischemic Stroke Drugs Market Size by Regions
  10. 2.3.1 North America Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Acute Ischemic Stroke Drugs Market Size Breakdown by Type (2021-2026)
3 Acute Ischemic Stroke Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Diagnostic Centers
  4. 3.1.3 Others
  5. 3.2 Global Acute Ischemic Stroke Drugs Market Size by Application
  6. 3.2.1 Global Acute Ischemic Stroke Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Acute Ischemic Stroke Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Acute Ischemic Stroke Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Acute Ischemic Stroke Drugs Market Size by Regions
  10. 3.3.1 North America Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Acute Ischemic Stroke Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Acute Ischemic Stroke Drugs Industry Trends
  2. 4.2 Acute Ischemic Stroke Drugs Industry Drivers
  3. 4.3 Acute Ischemic Stroke Drugs Industry Opportunities and Challenges
  4. 4.4 Acute Ischemic Stroke Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Acute Ischemic Stroke Drugs Revenue (2021-2026)
  2. 5.2 Global Acute Ischemic Stroke Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Acute Ischemic Stroke Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Acute Ischemic Stroke Drugs Company, Product Type & Application
  5. 5.5 Global Acute Ischemic Stroke Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Acute Ischemic Stroke Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Acute Ischemic Stroke Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Acute Ischemic Stroke Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Acute Ischemic Stroke Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson＆Johnson
  8. 6.2.1 Johnson＆Johnson Company Information
  9. 6.2.2 Johnson＆Johnson Business Overview
  10. 6.2.3 Johnson＆Johnson Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson＆Johnson Acute Ischemic Stroke Drugs Product Portfolio
  12. 6.2.5 Johnson＆Johnson Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Roche Acute Ischemic Stroke Drugs Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Acute Ischemic Stroke Drugs Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Biogen
  26. 6.5.1 Biogen Company Information
  27. 6.5.2 Biogen Business Overview
  28. 6.5.3 Biogen Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Biogen Acute Ischemic Stroke Drugs Product Portfolio
  30. 6.5.5 Biogen Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Acute Ischemic Stroke Drugs Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Acute Ischemic Stroke Drugs Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 ZZ Biotech
  44. 6.8.1 ZZ Biotech Company Information
  45. 6.8.2 ZZ Biotech Business Overview
  46. 6.8.3 ZZ Biotech Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 ZZ Biotech Acute Ischemic Stroke Drugs Product Portfolio
  48. 6.8.5 ZZ Biotech Recent Developments
  49. 6.9 SanBio
  50. 6.9.1 SanBio Company Information
  51. 6.9.2 SanBio Business Overview
  52. 6.9.3 SanBio Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 SanBio Acute Ischemic Stroke Drugs Product Portfolio
  54. 6.9.5 SanBio Recent Developments
  55. 6.10 NoNO Inc
  56. 6.10.1 NoNO Inc Company Information
  57. 6.10.2 NoNO Inc Business Overview
  58. 6.10.3 NoNO Inc Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 NoNO Inc Acute Ischemic Stroke Drugs Product Portfolio
  60. 6.10.5 NoNO Inc Recent Developments
  61. 6.11 Daiichi Sankyo
  62. 6.11.1 Daiichi Sankyo Company Information
  63. 6.11.2 Daiichi Sankyo Business Overview
  64. 6.11.3 Daiichi Sankyo Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Daiichi Sankyo Acute Ischemic Stroke Drugs Product Portfolio
  66. 6.11.5 Daiichi Sankyo Recent Developments
  67. 6.12 Bristol-Myers Squibb
  68. 6.12.1 Bristol-Myers Squibb Company Information
  69. 6.12.2 Bristol-Myers Squibb Business Overview
  70. 6.12.3 Bristol-Myers Squibb Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bristol-Myers Squibb Acute Ischemic Stroke Drugs Product Portfolio
  72. 6.12.5 Bristol-Myers Squibb Recent Developments
  73. 6.13 Boehringer Ingelheim
  74. 6.13.1 Boehringer Ingelheim Company Information
  75. 6.13.2 Boehringer Ingelheim Business Overview
  76. 6.13.3 Boehringer Ingelheim Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Boehringer Ingelheim Acute Ischemic Stroke Drugs Product Portfolio
  78. 6.13.5 Boehringer Ingelheim Recent Developments
  79. 6.14 Athersys
  80. 6.14.1 Athersys Company Information
  81. 6.14.2 Athersys Business Overview
  82. 6.14.3 Athersys Acute Ischemic Stroke Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Athersys Acute Ischemic Stroke Drugs Product Portfolio
  84. 6.14.5 Athersys Recent Developments
7 North America
  1. 7.1 North America Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Acute Ischemic Stroke Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Acute Ischemic Stroke Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Acute Ischemic Stroke Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst